ABSCIENCES (EPA:AB) AB Science announces positive top-line Phase 3 results for oral masitinib in severe asthma
Directive transparence : information réglementée
AB Science announces positive top-line Phase 3 results for oral masitinib...
AB Science announces the first presentation of preclinical results for...
AB Science has signed a financing agreement in order to pre-finance the...
AB Science will host a live webcast on indolent systemic mastocytosis on...
AB Science provides update on masitinib programs timelines
AB Science annouces the success of a private placement
AB Science to present at two upcoming conferences in September 2019, the...
AB Science reports the outcome from the interim analysis of study AB09004...
AB Science announces the positive recommendation of IDMC following the...
AB SCIENCE: Authorization to initiate phase 2 in T-Cell Lymphoma with...
Voir tous les communiqués de ABSCIENCES
©Dissemination technology Webdisclosure.com - copyright 2019 SYMEX ECONOMICS all rights reserved